Zentalis Pharmaceuticals, Inc.

ZNTL · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$39,072$37,599$41,929$33,901
Short-Term Investments$241,625$265,832$290,524$337,183
Receivables$0$0$0$5,000
Inventory$0$0$0$0
Other Curr. Assets$7,605$8,165$10,429$9,982
Total Curr. Assets$288,302$311,596$342,882$386,066
Property Plant & Equip (Net)$33,115$34,262$35,172$37,227
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$5,833$5,849$5,967$7,044
Total NC Assets$38,948$40,111$41,139$44,271
Other Assets$0$0$0$0
Total Assets$327,250$351,707$384,021$430,337
Liabilities
Payables$7,031$3,719$7,769$7,438
Short-Term Debt$0$0$0$3,072
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$30,137$35,303$41,661$42,215
Total Curr. Liab.$37,168$39,022$49,430$52,725
LT Debt$36,708$37,690$38,651$39,577
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$500$500$558$849
Total NC Liab.$37,208$38,190$39,209$40,426
Other Liabilities$0$0$0$0
Cap. Leases$36,708$37,690$38,651$42,649
Total Liabilities$74,376$77,212$88,639$93,151
Equity
Pref Stock$0$0$0$0
Common Stock$72$72$72$71
Retained Earnings-$1,156,239-$1,129,548-$1,102,674-$1,054,395
AOCI$186$59$358$558
Other Equity$1,408,855$1,403,912$1,397,626$1,390,952
Total Equity$252,874$274,495$295,382$337,186
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$327,250$351,707$384,021$430,337
Net Debt-$2,364$91-$3,278$8,748
Zentalis Pharmaceuticals, Inc. (ZNTL) Financial Statements & Key Stats | AlphaPilot